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1INTRODUCTION
Hydrocephalus is the most frequent neurosurgical problem encountered
in the paediatric age group with an incidence of 1 in 2000 births. It may also
occur as a complication of any insult to the nervous system like infections,
intra-ventricular haemorrhage, brain tumours, and head injury.28
Cerebrospinal fluid (CSF) shunting is a process by which CSF is
diverted from the lateral ventricles to another part of the body for absorption
Cerebrospinal fluid diversion devices are essential in the management of this
pathology 25. Ventriculoperitoneal shunt, a device inserted for the treatment of
hydrocephalus results in significant improvement in neurological function and
survival of patients.
Infection is one of the most serious complications after CSF shunt or
external ventricular drain placement. It increases both morbidity and mortality
and causes an increased incidence of seizures and neurological disturbances15.
        A typical CSF shunt comprises of three parts, a proximal portion –
ventricular catheter, which is inserted into the CSF space, a valve and
reservoir and a distal portion – terminating in the peritoneal
(ventriculoperitoneal shunt), pleural (ventriculopleural shunt) or vascular
space (ventriculoatrial shunt) .
2CSF shunts may become infected by retrograde infection from the
distal end, through the skin, by haematogenous seeding or by colonization at
the time of surgery 2.
The clinical features of shunt infection depend upon the pathogenesis
of infection, virulence of organism and the site of infection (proximal or distal
portion). Fever is typically present in the majority of patients. Other
symptoms seen are headache, nausea, vomiting, lethargy, changes in mental
status, seizures, pain at the distal end and features of peritonitis.
Children are more likely to acquire shunt infections than adults
because of immature immune system, long hospital stay and higher
concentration of bacteria in the skin2. Some of the factors commonly
associated with increased risk of CSF shunt infection are premature birth,
aetiology of hydrocephalus, previous shunt infection, length of procedure and
shunt revision. About 90% of infections are diagnosed in the first 6 months,
majority in the first 3 months23.
The organisms frequently isolated from CSF shunt infections are
Staphylococcus epidermidis (47-64%), followed by S.aureus (12-29%) and
gram negative bacilli  like Escherichia coli, Klebsiella, Proteus and
Pseudomonas species (19- 22%).
3Diagnosis is established by direct culture of the CSF or of fluid within
or around the shunt or ventricular reservoir. CSF obtained from the ventricular
reservoir is ideal for culture. Neuroimaging studies are not useful in
identifying shunt infection but show evidence of shunt malfunction.
Treatment of shunt infection includes shunt removal, insertion of
external ventricular drain (EVD) and administration of intravenous antibiotics
for 7-10 days. Intraventricular antibiotics, via the reservoir or EVD may be
required for those not responding to systemic antibiotics. Reshunting is
usually done after 7-10 days of antibiotic therapy or when culture becomes
negative. Removal of shunt hardware with shunt replacement and intravenous
antimicrobial therapy cures approximately 65-75% of patients with shunt
infections.
4AIM OF THE STUDY
? To isolate the causative organisms.
? To assess the risk factors associated with shunt infection.
? To find the incidence of infection associated with shunt related
procedures.
? To determine the antimicrobial susceptibility pattern of the isolates to
aid in management.
? To evaluate the outcome of management.
5REVIEW OF LITERATURE
Approximately 25,000 shunts are estimated to be placed each year in
North America and about twice as many are revised (total of 75,000 shunt
operations). Shunt operations are the most frequently performed procedures
by paediatric neurosurgeons 29.
The word shunt is derived from the English word shun, which denotes
being pushed away, suggesting diversion. This seems to be appropriate as the
fundamental role of shunts is diverting CSF from within the ventricles to an
alternative location outside the subarachnoid space 29.
The most common distal site for diversion is the peritoneum and these
are described ventriculoperitoneal shunts.
History of shunting
It was Hippocrates who made the first attempt to drain ventricular CSF
in a case of hydrocephalus17.The first attempt to drain CSF into the peritoneal
cavity was recorded in 1898, when a silver wire was introduced into the
peritoneal cavity through the vertebral body of L5 in the hope of creating a
fistula to drain CSF 5.
In 1907, CSF diversion into the superior sagital sinus was attempted,
but the mortality rate was 100% 5.
6In 1939, Torkildsen performed a shunt from the lateral ventricle to the
cisterna magna and the mortality rate was 50% 5.
In 1952, Nulsen and Spitz made a significant contribution to the
treatment of hydrocephalus by introducing the first valve regulated shunt
system to prevent the reflux of venous blood 45.
In 1960, Ransohoff et al recorded a success rate of 65% with
ventriculopleural shunts51.
It was reported by Scarff that 55% of 230 patients had arrested
hydrocephalus after placement of a VP shunt in 196355.
In the 1970s, Ames’ work suggested that the peritoneal cavity was the
best site for   diversion of CSF5.
The first VP shunt placement is attributed to Cushing in 1908. But, VP
shunts did not  gain popularity until 1963,when Scarff published his work 55 .
Venticuloperitoneal shunts became first-line therapy for the treatment
of hydrocephalus in the 1970s.
7HYDROCEPHALUS
Definition
Hydrocephalus is an excessive accumulation of CSF within the head
caused by a disturbance of formation, flow or absorption.
Cerebrospinal fluid (CSF)
The intracranial compartment volume consists of 100-150 ml CSF, 100
ml blood and 1000-1200 mg brain. The cerebral perfusion pressure ranges
from 50-150mm H205.
The normal CSF production rate in an adult is 0.37 ml/min (20 ml
/hour or 500 ml/24 hours) 16.
The CSF is normally clear with a glucose concentration of about 45 to
100 mg/dl, which depends on blood sugar levels and protein concentration of
about 14 and 45 mg/dl. It is sterile with a cell count of less than 5
lymphocytes per ml.
The capacity of normal lateral and third ventricles is approximately 20
ml, whereas the total CSF volume is 120 – 150 ml. In normal circumstances
CSF is recycled over 3 times each day.
8Pathophysiology of Hydrocephalus
Physiologically, hydrocephalus is a hydrodynamic disorder in which
the volume of CSF in the subarachnoid and / or ventricular spaces is
abnormally elevated due to overproduction, underabsorption, both or
increased venous pressure5.
The accumulation of fluid in various intracranial compartments was
recognised by Hippocrates (BC 460-377) and Claudius Galen (130-200 AD).
The first morphological description of hydrocephalus is attributed to Andreus
Vesalius (1514-64) who recognised the ventricular enlargement and brain
destruction. Thomas Willis (1621-75) was the first to propose that choroid
plexus is the site of CSF production. 6
It is presumed that 50-80% of the CSF is produced in the choroid
plexus lining the walls of the lateral ventricles, roof of third and fourth
ventricles48. Once formed in lateral ventricles, CSF circulates through the
foramen of Monro, the third ventricle, the aqueduct of Sylvius and the fourth
ventricle and exits through the foramen of Luschka and Magendie, where it
flows into the basilar cisterns and subarachnoid granulations in the inner table
of the sagittal sinus and skull.
9Flow of CSF depends on four factors:
? Production,
? absorption,
? resistance and
? sagittal sinus pressure5.
An obstruction at any point along the CSF pathway may result in
hydrocephalus6.
AETIOLOGY OF HYDROCEPHALUS
Hydrocephalus can be classified into 2 types.
1.  Non communicating hydrocephalus (Obstructive hydrocephalus)
When the aetiology lies within the ventricular system or at the fourth
ventricular outflow.
2.  Communicating hydrocephalus
When the aetiology impairs circulation through the subarachnoid space
or absorption into the venous system6.
Hydrocephalus can be further divided into congenital and acquired forms.
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Types of hydrocephalus
OBSTRUCTIVE COMMUNICATING
Congenital Congenital
1.  Aqueductal stenoses 1. Arnold Chiari malformation
2. Dandy Walker malformation 2. Encephaloceles
3. Benign intracranial cysts
(Arachnoid cysts)
3. Skull base deformity
4. Vascular malformation
 ( Eg. Vein of Galen aneurysms)
             Acquired                        Acquired
1.  Tumours (Eg. third ventricle,
pineal and posterior fossa
tumours)
1. Infection (Intra ventricular
eg.CMV, Toxoplasma, Post
bacterial)
2. Other mass lesions
 (Eg.Giant aneurysm, abscess)
2. Haemorrhage (Intraventricular
haemorrhage of infancy,
Subarachnoid haemorrhage)
3. Ventricular scarring 3. Venous hypertension (Venous
Sinus thrombosis, Arterio –venous
shunts)
4.  Meningeal carcinomatosis
5.  Choroid plexus papillomas
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Ventriculo-peritoneal shunting-Goals of surgery
The goals of surgery for hydrocephalus are:
1.  To reduce intracranial pressure
2.  To maximally improve the patients neurological outcome and
3. To maximize the size of the cortical mantle and minimizing
complications
These goals can be achieved by diverting CSF through a shunting
apparatus that includes a ventricular catheter, valve (with or without a
reservoir) and distal absorption site5.
About 25% of patients with hydrocephalus (10% with aqueductal
stenosis , 10 %  with tumours and 5% with cysts) can be cured without a
shunt 54.
Hydrocephalus should be treated to prevent destruction of brain mass
by ventriculomegaly. Edema of white matter leads to fibrosis, degeneration of
neurons and neuronal loss.64 Distortion of cerebral blood vessels and collapse
of capillaries occur with resultant impaired cerebral blood flow. Severe
hydrocephalus may cause infarction of posterior cerebral artery. The final
consequences are herniation, death or cortical blindness 5.
Thus the ultimate goal in the treatment of hydrocephalus is to prevent
this cascade of events.
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Clinical features of hydrocephalus
       Infants with progressive ventriculomegaly have rapidly enlarging heads
(increase in circumference > 2 cm/week) and symptoms of increasing
intracranial pressure (tense fontanelles, vomiting, poor feeding, bradycardia
and progressive apnoea)
Adults present with symptoms such as headache, vomiting, failing
vision, drowsiness, unsteadiness and slowing of mental capacity.
Signs - Papilloedema, enlarged blind spots, reduced visual acuity, large
head, dyspraxic   gait, general clumsiness.
Indications for CSF shunt surgery
CSF shunting procedures must be performed in patients in whom
hydrocephalus cannot be treated conservatively. Some of the indications
include idiopathic hydrocephalus, communicating or obstructive
hydrocephalus, failed third ventriculostomy, CSF leakage or
pseudomeningocele and signs and symptoms of brain stem compression.
Communicating hydrocephalus is usually caused by intraventricular or
subarachnoid haemorrhage, trauma or infection 5.
Ultimately, shunting is decided for each individual based on a risk
benefit ratio .
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Pre-operative investigations
Radiographic imaging and diagnosis of hydrocephalus must be done
before surgery.
MRI is the best diagnostic tool in establishing the anatomy and likely
pathology of obstructive lesions.
Computed tomography (CT) is required for follow – up of patients
with already existing shunt system and also for urgent evaluation of
undiagnosed patients .
Ultrasound performed through open fontanelles is the only possible
approach in critically ill premature infants with intraventricular haemorrhage
or with meningomyclocele1.
Ventricular shunting procedures
The proximal portion of a CSF shunt is commonly placed in one of the
cerebral ventricles, but may also be placed in an intracranial cyst or the
lumbar subarachnoid space 25 .       The distal placement sites that have been
proved to be reliable over time include the peritoneum (ventriculoperitoneal
shunt), the atrium (ventriculoatrial shunt ) and the pleura (ventriculopleural
shunt). CSF is sometimes drained from the lumbar spinal theca to the
peritoneal cavity (lumboperitoneal).
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Components of a Shunt System
Every shunt system consists of 3 central components – a ventricular
catheter, a valve and a distal catheter. Simple shunts have only these 3
components.
Additional components such as tapping reservoirs, on-off devices,
pressure transducers, and antisiphon devices may also be present in complex
shunts as required for multiloculated hydrocephalus as in Dandy walker
malformation.
Ventricular Catheter
This is the component that extends from the lateral ventricle to the
valve. The tip of the rostral end is rounded and there are multiple holes along
the proximal shaft of the catheter.
Shunt valves
Valve designing has gained the maximum attention in the development
of effective shunt systems, following the development of Spitz–Holter and
Pudenz valve using silicone.
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Valves can be classified into three types
1. Fixed pressure valve
Eg. Hakim valve, PS medical valve and Chabbra valve which is
manufactured in India and   widely used throughout the world.
2.  Flow regulated valve
Eg. Delta valve and OBV II
3.  Programmable pressure valve
Eg. Strata, Sophy and Polaris. They play a valuable role in treating
adults with hydrocephalus.
Distal catheter
Despite being the longest and the largest component of a shunt, the
distal catheter often functions the best with the fewest problems. Barium
impregnation allows the radiographic visualization of the location of the
catheter.
VENTRICULOPERITONEAL SHUNT
Procedure
? A small semilunar skin incision is made and an occipital burr hole
placed on the flat part of occiput, 3-4 cm from the midline along the
course of lambdoid   suture. If a frontal burr hole is required, it is
placed along coronal suture 2-3 cm from midline.
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? Abdominal incision is made in para-umbilical and upper midline sites.
? A subcutaneous pocket is designed to house the shunt apparatus
? Shunt tube passer is passed from abdominal incision to cranial incision
by gentle subcutaneous tunnelling.
? Peritoneal catheter is passed through the tunnelling device from cranial
to abdominal end.
? Insertion into peritoneal cavity is by mini-laparotomy or using trocar.
? Ventricular catheter is introduced into the lateral ventricle and
positioned at right angle to the burr hole, the tip anterior to the foramen
of Monro. CSF is taken for culture.
? Flushing device is connected to both distal and proximal catheters.
Shunt system is then secured to pericranium to prevent migration.
After checking for flow of CSF, skin is closed in two layers.
? Prophylactic antibiotics are administered intravenously pre-operatively
and a few doses postoperatively.28
Complications of Shunts
Mechanical failure and infection together account for the vast majority
of shunt complications6. Some of the commonly encountered shunts are:
? Infection
? Shunt blockages (proximal, valve or distal)
? Fracture or disconnection
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? Migration
? Overdrainage
? Isolation(trapping) of ventricles
? Malposition
? Intracranial haemorrhage
? Viscus perforation
Blockage –
Shunt obstruction is the commonest indication for shunt revision. In
the majority, it is due to blockage of ventricular catheter by choroid plexus,
brain tissue and cellular debris.
The Slit Ventricle Syndrome
This condition presents clinically with episodic headache which is
positional, vomiting and reservoir may be slow to refill. CT shows slit-like
ventricles. It is due to loss of compliance of ventricular wall, with the small
volume ventricle intermittently collapsing around the catheter and causing
temporary blockage.
Abdominal complications
Viscus perforation can occur either as a complication of the initial
insertion or as result of chronic erosion of the catheter tip through the viscus
wall. Perforation of stomach, large and small bowel, gall bladder and vagina
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are described. There may be signs of peritoneal sepsis or occasional extrusion
of the catheter tip at the anus, umbilicus or vagina. Catheter disconnected and
lost in peritoneal cavity can lead to symptoms and make it difficult to
eradicate infection.
Intraabdominal fluid collection
Formation of localised CSF collection within peritoneal cavity is
common. Abdominal pain and distension are the common symptoms. They
can be readily diagnosed by ultrasound. Presence of pseudocyst generally
indicates underlying infection in two-thirds or more of cases.21In such cases
management is aimed at eradication of the infection by removal or
externalization of the infected shunt.6
CSF Shunt Infection
Because of their frequency and associated morbidity and cost, infection
of CNS shunts remains a significant problem in neurosurgery. Certainly, early
detection and aggressive treatment to promptly clear these infections reduces
morbidity.
Epidemiology
The incidence of shunt infection can be described as ‘case infection
rate’ – the occurrence of infection per given patient, or as an ‘operative
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infection rate’ – the occurrence of infection per procedure. The case incidence
of shunt infection ranges from 8-40% and the operative incidence ranges from
2.8-14% as reported from various studies since 1971.56
It has been observed that the distribution of shunt infections is bimodal
since last shunt surgery.33
70-85% of infections have presented by 6 months post operatively and
the second peak after 12 months. 23
Patient skin preparation and exposure of large areas of patient’s skin
during the procedures have been considered as sources of infection. 50
Externalized device infection rate has been found to be in the range of
5-7%.30
Prolonged externalization is the most common risk factor associated
with infection.47
Aetiology
More than two–thirds of all CSF infections are caused by
Staphylococcal species; S.epidermidis (47-64%) followed by S.aureus
(12-29%) 34,20.
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             Gram negative bacilli account for 6-20% of infections, E.coli and
Klebsiella spp being more frequent .Proteus and Pseudomonas species are
not infrequently isolated.
Streptococcal species account for 8-10% infections.
The traditional meningitis pathogens-H.influenzae, S.pneumoniae and
N.meningitidis, are seen in approximately 5% of infections.57 ,41,37
Multiple organisms are implicated in 10-15% of patients, with one
isolated organism usually being Staphylococcal species or E.coli. 56, 23, 46
Shunt system with peritoneal end have been considered at greater risk
of infection with gram negative organisms more common to the gut. 66, 22
This is more often due to perforation of a hollow viscus by the catheter
causing a mixed infection of gram negative bacilli.22
Fungal infections of shunt are rare, but they may occur because of the
increased number of susceptible patients. The factors contributing to fungal
infections are prior use of broad spectrum antibiotics, hyperalimentation,
leukaemia, diabetes mellitus, corticosteroid use and immunocompromised
states (AIDS, post chemotherapy, post transplantation) 62
21
Pathogenesis
There are four mechanisms by which CSF shunts may become infected 31
1. Retrograde infection from the distal end
2. Through the skin
3. Haematogenous seeding
4. Colonization during surgery
Retrograde infection from the distal end of the shunt is rare and may
occur as a result of bowel perforation. It is the most likely mechanism of
infection of external ventricular devices (EVDs). Microorganisms may enter
the device from the exit site or during injection through the tubing.
The second mechanism is through the skin, such as inserting a needle
into the reservoir or the shunt to culture the CSF or assess patency or for
injecting drugs and by breakdown of the skin overlying the shunt.
The infection may be due to failure of the incision to heal, or due to
scratching of the wound or the other spontaneous infections of the skin.
Haematogenous seeding causing shunt infection is unusual in VP
shunts, but very common in ventriculoatrial shunts.
Colonization of the catheter during surgery is the main mechanism of
shunt related infections. 31 This is suggested by the timing of the shunt
infections and by the microorganisms isolated. In one study, 62% of infections
22
occurred within the first month after shunt surgery and 72% were acquired
intraoperatively. 2
Direct exposure and handling of the shunt during the surgery allows
bacterial contamination. Other interrelated factors may also be associated with
the colonization of the devices. In vitro studies have shown that shunt
catheters reduce neutrophil chemotaxis and the ability to phagocytose bacteria
effectively.25
Bacterial adherence to the shunt is the initial step for the colonization
and infection of the device.25 Catheter biomaterial is altered with passage of
time, enabling adherence of microorganism and formation of a mucoid film
called biofilm or slime.
This is a polysachharide film that incorporates bacterial micro colonies
and interferes with phagocytosis, immune response and antibiotic penetration.
Also, an increased genetic transference among bacteria forming the slime
causes a higher resistance to antibiotics.
RISK FACTORS
Factors associated with an increased risk of cerebrospinal fluid shunt
infection are:
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? Premature birth
? Younger age
? Previous shunt infection
? Cause of hydrocephalus
? Experience of the neurosurgeon
? Number of people traversing the operating theatre
? Exposure to perforated surgical gloves
? Intraoperative use of the neuroendocope
?  Length of the shunt procedure
? Patient skin preparation
? Shaving of skin
? Exposure of large areas of patient’s skin during the procedure.
? Shunt revision
The factor most commonly associated with increase in shunt infection
is the patient’s age.23,63,5 The risk is higher in neonates, especially premature
infants and the elderly.23
Another important factor is prematurity 34, 40, 50, 52 This is explained by
changes in the density and microbial flora of skin according to the age and
higher susceptibility to infection due to a deficiency in immune system. The
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IgG levels in infants less than 6 months of age is just half of those present in
adults .50,52
Among the other risk factors, previous shunt infection 40,52, post
operative CSF leak 18,34 ,neurosurgeons experience 8,23 and spinal dysraphism
are the most accepted ones.
Clinical features
The clinical features of shunt infection are variable, depending on the
pathogenesis of infection, virulence of organism and type of shunt.31,63,22.
The most common symptoms are headache, nausea, lethargy and
changes is mental status (seen in about 65% of infected patients) which occur
in shunt malfunction secondary to the infection.
Fever is reported in as few as 14% to as many as 92% of cases.
Although present in majority of patients, absence of fever does not exclude
infection.
Symptoms and signs are referable to the proximal or distal portion of
the shunt .Infections arising in the proximal portion of the shunt causes
meningitis or ventriculitis in about 30% of cases with resultant shunt
obstruction or decreased function.
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Symptoms referable to the distal portion may be due to peritonitis such
as fever, anorexia, abdominal distension and other signs of acute abdomen.
With low virulence organisms few signs such as abdominal tenderness or
guarding only may be present. There may be fluid collections due to
encystment of the shunt catheter.  The deposited CSF is not absorbed causing
loculation of pockets of fluid within the abdomen resulting in partial or
complete shunt obstruction.
Some shunt infections are insidious and cause few or no symptoms
such as intermittent low grade fever or general malaise.
Diagnosis
The diagnosis of CSF shunt infections is made by culture of the shunt
CSF or of the fluid within or around the shunt.57,22 Fluid can be obtained from
the reservoir by tapping percutaneously under strict aseptic precautions.
Lumbar CSF cultures are usually negative in shunt infections. Lumbar CSF
cell count, glucose and protein concentrations also may not indicate infection.
Blood leukocyte counts have a limited value as they are normal in
about 25% of infections.36,57,39
Blood culture is also of limited value. But it is positive in up to 90% of
vascular shunts.
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The CSF sample, once tapped is subjected to cell count including
differential count, biochemical analysis (CSF glucose and protein), gram stain
and culture.
High white blood cell counts reflect infection, but infection may be
present even with normal cell counts. Normally the CSF has less than 5
lymphocytes per ml.
CSF eosinophil count may be elevated and has been found to be
associated with indolent infection.
Cell counts may be altered by recent surgery due to inflammatory
response (chemical meningitis) or due to the spilled blood.
The CSF glucose level may be reduced and protein levels elevated.
Glucose levels may be in the normal range in most cases and is not very
useful.
Gram staining may be of some value in denoting the type of causative
microorganism. Again a negative result does not exclude infection. 46
Routine analysis of the above said parameters may not have an
accurate predictive value as a marker of infection.36,57,38
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CSF culture from the shunt or reservoir is the most valuable test in
establishing the diagnosis of infection. Cultures are usually positive even in
the absence of CSF pleocytosis or abnormal biochemical parameters.
Administration of antibiotics in patients with suspected shunt infection
before CSF culture reduces the likelihood of obtaining a positive culture.
Cultures may require several days of incubation before being discarded as
negative.
Occasionally, a positive culture may be reported in shunts tapped for
evaluation of function in the absence of infections. The likely reason being
contamination, shunt should be retapped for culture. A repeat positive culture
indicates true infection.
In patients with external ventricular drain, CSF pleocytosis and a
positive culture (obtained from the ventricular catheter) indicates definite
infection.
On the other hand, absence of a positive gram stain of CSF culture but
a progressive decrease in CSF glucose and increase in CSF protein with
advancing pleocytosis indicates a suspected infection.
A contaminating microorganism is defined as an isolated positive CSF
culture and / or positive gram stain with normal biochemical parameters and
cell counts.
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When infection is limited to the distal portion of the VP shunt, culture
of the reservoir fluid may be negative in the absence of retrograde infection.
However, patients with distal occlusion of VP shunt presenting as acute
abdomen should undergo early revision and get investigated for possible
infection. A CT or ultrasound scan of the abdomen may identify CSF
loculations at the terminus. Peritoneal symptoms usually clear within 12 hours
after removal of an infected distal catheter.
IMAGING STUDIES
1.  Plain radiographs are used to determine whether a shunt system is in
continuity
2.  In many cases, shunt infection causes a degree of shunt obstruction
causing increased ventricular size. This is easily seen on an ultrasound
scan if fontanelles are open or with CT scan or MRI.
3.  Peritoneal infection results in the formation of loculated fluid
collections detected by sonography or CT.
Abdominal pseudocyst is caused by a progressive accumulation of
fluid due to localized reaction of the omentum. Antibiotic treatment usually
results in rapid improvement.
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Treatment
Most shunt infections caused by Staphylococcus spp. do not cause
significant tissue damage or a severe inflammatory response. Intravenous
antibiotic treatment usually results in rapid bacteriologic clearance with
resolution of the CSF pleocytosis.
Aims of the treatment of CSF shunt infections are:
1.  Reduction in mortality and morbidity due to the complication of
operative treatment
2.  Maintenance of a functioning device and
3.  Cure for infection .25
Factors to be considered in the therapy of an infected CSF shunt include:
1. Selection of antimicrobial therapy
2. Timing of hardware removal
3. Timing of shunt replacement and
4. Duration of antimicrobial therapy.2
Antimicrobial therapy
The antimicrobial agent selected must penetrate the central nervous
system and have bactericidal activity against the infecting pathogen.
Empirical therapy is initiated when the culture results are awaited. The most
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likely organisms associated with shunt infections are CONS, S.aureus and
gram negative bacilli. Hence empirical therapy with vancomycin plus either
cefepime, ceftazidime or meropenam would be appropriate. Once cultures
have returned, antibiotics can be selected based on the identified organism
and drug sensitivities. For example in the absence of methicillin resistant
S.aureus or pencillin allergic patients both S.epidermidis and S.aureus can be
treated with oxacillin or nafcillin with good results.43
For Candida shunt infection, intravenous amphotericin-B often
combined with 5 flucytosine or fluconazole is recommennded.2
Direct instillation of antimicrobial agents into the ventricles may be
required when the shunt infections are difficult to eradicate or when the
patient is unable to undergo surgery.
The doses of antimicrobial agents for intraventricular use have been
determined empirically based on the ability of the agent to achieve adequate
CSF concentration.53, 27
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Antimicrobial agents administered by the intraventricular route
Antimicrobial agent Daily intraventricular dose
Vancomycin 5-20 mg.
Gentamicin 1-8 mg.
Tobramycin 5-20 mg.
Amikacin 5-50 mg.
Polymixin B 5 mg.
Colistin 10 mg.
Teicoplanin 5-40 mg.
Amphotericin B 0.1-0.5 mg
SHUNT REMOVAL AND REPLACEMENT
Shunt removal with immediate placement
Removal of shunt hardware with immediate shunt replacement and
intravenous antimicrobial therapy cures approximately 65 % to 75 % of
patients with shunt infections.
Shunt removal with delayed replacement
       Shunt removal, antimicrobial therapy in the absence of any foreign
devices and delayed replacement is another option, but the reason for which
the shunt was placed initially is left untreated.63
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Shunt removal with placement of an exrernal CSF drain
Antimicrobial use, removal of all components of the infected shunt and
the use of some component of external drainage appears to be the most
effective treatment for CSF shunt infection.65
A new shunt is usually not placed until CSF culture is negative for
bacterial growth. The recommnended interval between shunt revision and
reinsertion is approximately 10-14 days with atleast 48 hours between the
final negative CSF culture and reinsertion.43
In this interval, a variety of methods are used to support shunt deprived
patients that include shunt exteriorization, placement of external ventricular
drain or lumbar drainage catheters.
In premature infants with very low birth weight, intermittent lumbar
puncture or ventricular tapping can be preformed.
Ventriculitis of shunt infections clear more quickly with external
drainage, the treatment success usually greater than 85 % .31, 66, The greatest
risk of the EVD is that of secondary infection.31, 38  Maintaining a sterile
closed system and avoiding injections into the system usually reduces this
risk.
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Duration of Antimicrobial therapy and Shunt reinsertion
In patients with shunt infection caused by CONS with normal CSF
findings, negative cultures for 48 hours after externalization confirms a cure
and patient can be reshunted on the third day after removal.
If CONS was isolated with abnormal CSF biochemistry and
pleocytosis, 7 days of antimicrobial therapy is recommended once repeat
culture is negative before reshunting.
        For shunt infections caused by S.aureus or gram negative bacilli, 10 days
of antimicrobial therapy with negative culture is recommended before
reshunting.31, 12
        Regardless of the manner of treatment, CSF shunt infection can recur. In
one study, the recurrence rate was 26%, with two thirds of cases caused by the
same microrganisms.32
Prevention
Good surgical techniques and adherence to infection control measures
are important in preventing infection. Double gloving may decrease CSF
shunt infection rates.59
Several meta-analyses have concluded that periprocedural prophylactic
antibiotics can reduce rates of infection by about 50%.26
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Antibiotic impregnated catheters for EVD and CSF shunts have been
shown to reduce colonization and infection of the catheter with gram- positive
organisms.67, 24
A prospective trial of 306 patients with placement of EVDs
impregnated with minocycline and rifampin showed reduction in the infection
rate from 9.4 % to 1.3 %.67
    Another trial of 110 patients with placement of shunts impregnated
with clindamycin and rifampin showed a decrease in infection rate from 16.6
% to 6 %.
Future developments
Future advances in technology, such as nanocoatings for shunt
components should increase the biocompatibility of shunt system prolonging
the life span. Measures such as avoiding barium impregnated catheters and
removing distal slit valves can also prolong shunt survival.
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MATERIALS AND METHODS
This is a cross sectional study involving 397 patients, among whom
275 patients had undergone primary ventriculoperitoneal shunt insertion and
122 patients had undergone shunt related procedures like shunt removal,
revision, reinsertion, exteriorization and external ventricular drain placement.
In this study population, 122 cases had developed symptoms of shunt
infection and malfunction.
Place of study
Institute of Microbiology and Institute of Neurosurgery, Rajiv Gandhi
Government General Hospital & Madras Medical College, Chennai.
Period of Study
November 2011- October 2012
Ethical consideration
Approval was obtained from the Institutional Ethics Committee before
the study was commenced. Informed consent was obtained from the study
population. All patients satisfying the inclusion criteria were included in the
study and they were interviewed by a structured questionnaire.
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Study Group
122 patients who showed signs and symptoms of shunt infection and
malfunction were included in the study. Patients of both sexes and belonging
to all age groups were evaluated. Patients with hydrocephalus who had
previously undergone ventriculoperitoneal shunt insertion and presenting with
symptoms and signs suggestive of shunt infection or malfunction during the
study period and who had undergone shunt related procedures were evaluated.
Relevant data were collected from the patients as mentioned in the
enclosed proforma. They include patients’ age and sex, aetiology of the
hydrocephalus requiring ventriculoperitoneal shunt, date of shunt placement,
number of prior revisions, history of prior shunt infections, results of culture
of CSF, shunt tube or pus and follow-up.
COLLECTION AND TRANSPORT OF SPECIMENS
The samples that were collected for culture include
1.  Cerebrospinal fluid
2.  Ventriculoperitoneal shunt tube
3.  Wound swab from sites of wound infection-proximal or distal and
4.  Intraabdominal fluid collections
5.  Blood.
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All the samples were collected from the patients under strict aseptic
precautions and processed immediately.
Cerebrospinal Fluid
In suspected cases of CSF shunt infections, CSF was obtained under
strict aseptic conditions by lumbar puncture or percutaneous puncture of
ventricular reservoir which is in an easily accessible subcutaneous location or
from the external ventricular drain.
Lumbar puncture technique
1.  The patient is made to lie on the side with knees flexed and back
arched.
2.  The area over the lumbar spine is disinfected.
3.  The space between the vertebrae L3 and L4 is palpated.
4.  With aseptic precautions, the spinal needle is inserted into the spinal
canal through the intraspinous ligaments and CSF is tapped.
In patients undergoing surgery for revision, removal or replacement of
the shunt device, CSF is collected directly from the lateral ventricles through
the ventricular or peritoneal catheter.
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CSF was collected from each patient in 3 separate sterile test tubes.
The tubes were screw capped or plugged with sterile cotton.
One tube was used for biochemical analysis - for CSF glucose and
protein.
Second tube was used for Gram stain and culture.
Third tube was used for cell count and differential staining. CSF
samples were processed immediately in the laboratory.
Ventriculoperitoneal shunt tube
The CSF shunt tubes used for culture included a part of the tube or the
entire tube depending on the procedures the patients underwent.
In patients who had undergone revision of the cranial or the peritoneal
end of the shunt tube, the ventricular catheter (with or without the reservoir)
or the peritoneal catheter respectively was processed. In patients who had
undergone removal of the entire CSF shunt tube, the tips of both the ends-
ventricular and peritoneal were subjected to Gram stain and culture.
Wound Swab
Wound swabs were taken from patients with CSF shunts who
developed wound infection of the incisional surgical site.
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The infected site was decontaminated with 70% ethanol, washed with
normal saline and dried before taking a swab. Two specimens were collected
using sterile cotton swabs from the depths of the lesion, one for Gram stain
and the other swab for culture which was processed immediately.
Intraabdominal fluid collection
CSF or pus collection within the peritoneal cavity aspirated at the time
of revision surgery was collected in sterile test tubes and processed
immediately.
Blood
Blood was collected from patients after careful preparation of the
venipuncture site with povidone iodine and 70% alcohol. About 10-15 ml of
blood was collected from adults and 5-10 ml from children using disposable
needle and syringe and inoculated into brain – heart infusion broths directly
and incubated at 37oC.
PROCESSING OF SAMPLES
Processing of CSF
CSF was tested for cell count and biochemical analysis and reports
documented.
Measurement of CSF glucose and protein
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The CSF glucose level was measured using a calorimeter. The normal
CSF glucose levels are between 45 and 100 mg/dl.
The CSF protein concentration was also measured by calorimetric
method. Normally, the CSF protein concentration is in the range of 14 to 45
mg/dl.
Macroscopic appearance
The CSF sample was examined macroscopically for turbidity and
deposits, and whether purulent or blood obtained.
Gram Stain
The CSF specimen was centrifuged to concentrate the bacteria and
from the sediment, a smear of about 1 cm diameter was made on a clean glass
slide and marked. The smear was allowed to air dry and Gram staining was
done. The stained smear was examined for presence of pus cells and
organisms.
Culture
Culture is the standard diagnostic method to detect bacterial infections.
The sediment of the centrifuged CSF specimen was inoculated on
MacConkey agar, blood agar and chocolate agar plates. The first two plates
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were inoculated at 37oC for 24-48 hours. The chocolate agar plate was
incubated at 37oC in candle jar with 5% CO2 for 24-72 hours.
The plates were examined after 24 hours and if any growth was
observed, the colony morphology was noted and a smear made from the
colonies for Gram stain, The plates showing no growth were incubated further
for another 24-48 hours.
The morphology and the staining characteristics of the isolates helps in
preliminary identification.
Motility of the bacteria was demonstrated by hanging drop method
after incubating a peptone water culture for 2 hours at 37o C.
Identification of the isolates was done by processing the colonies
further by biochemical tests for assessing the metabolic characteristics. They
include catalase test, oxidase test, carbohydrate utilization test, indole
production, Methyl red test, Voges Proskauer test, Citrate Utilization, Urease
production,  Decarboxylation of lysine,ornithine and arginine, Phenylalanine
deaminase production,Nitrate reduction, Hugh & Leifson’s O/F test
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PROCESSING OF SHUNT TIPS
Macroscopic examination
Shunt tips were examined macroscopically for biofilms or slime.
Gram stain
Smear was made from any fluid within the ventricular reservoir and
Gram staining was done. The stained smear was examined for pus cells and
organisms.
Culture
If any fluid was noted in the ventricular reservoir, the tube was gently
squeezed and the expressed fluid plated on to culture plates. The ventricular
catheter and the peritoneal catheter tips irrespective of the presence or
absence of fluid within the tube placed in separate tubes of brain heart
infusion broth and incubated at 37oC for 18-24 hours.
After overnight incubation, the broths were observed for turbidity and
subcultured onto MacConkey agar, blood agar and chocolate agar plates and
incubated for 24-48 hours at 37oC as done for CSF specimen. Further
processing done as for CSF,
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WOUND SWABS & INTRAABDOMINAL FLUID COLLECTION
Direct gram stain:
Smear examined for any pus cells or bacteria
Culture:
Specimens plated on to culture plates as done for CSF and processed.
Blood
After 48 hours of incubation, the BHI broth inoculated with blood was
observed for turbidity and haemolysis and subcultured on MacConkey agar,
blood agar and chocolate agar plates and incubated at 370C .Further
processing carried out as done for the previous specimens.
Interpretation of bacterial cultures
Bacterial isolates were identified by means of colony morphology,
Gram staining, motility and biochemical reactions by standard
microbiological techniques as recommended by Clinical and Laboratory
Standards Institute. (CLSI).14
44
Antimicrobial Susceptibility Testing:
 Antimicrobial susceptibility testing was done on Mueller-Hinton agar
(MHA) [Hi-media laboratories, Mumbai, India]. Four to five colonies of pure
growth from an overnight culture of organism was transferred to a tube
containing 4-5 ml of peptone water and incubated at 37ºC for 2 hrs and
adjusted to match 0.5McFarland turbidity. A lawn culture of the isolate was
made on MHA with a sterile cotton swab and antibiotic discs (Hi-Media
Laboratories, Mumbai, India) were placed at appropriate distances and
incubated at 35 + 2ºC in ambient air for 16-18 hours.[4] Standard strains of
Staphylococcus aureus-(ATCC 25923), E.coli (ATCC 25922) and
P.aeruginosa (ATCC 27853) were used as controls and tested in a similar
way. The zone of inhibition was measured carefully and interpreted according
to CLSI 2011 guidelines.14 The antibiotics tested are listed in the tables below.
Modified Hodge Test (MHT):
A 0.5 McFarland of ATCC E.coli 25922 was prepared by direct colony
suspension method. It was diluted 1:10 in normal saline, and a lawn culture
was made on MHA plate. Plate was allowed to dry for 5 to 10 minutes, and
imipenem disc was placed in the centre of the plate. 3-5 colonies of test and
QC organism (ATCC Pseudomonas aeruginosa 27853) grown overnight on a
blood agar plate were taken with a 4 mm loop and inoculated in a straight line
of 20-25 mm out from the edge of the disc. The plate was incubated for 16- 20
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hours at 35 + 2 ºC in ambient air. Enhanced growth at the intersection of
streak and zone of inhibition was interpreted as positive for possible MBL
production. As carbapenemase produced by the test organism inactivates the
imipenem which diffused into the medium, growth of ATCC E.coli 25922 was
enhanced around the MBL producing test organism.[5,6,7]
Combination Disc Test(CDT):
Discs of imipenem (IPM-10µg) and imipenem-EDTA (IE-10+750µg)
were placed on a MHA plate inoculated with 0.5 McFarland turbidity of the
test isolate and incubated at 35 + 2 ºC for18- 24 hours. Any isolate showing
an increase in zone size of at least 7 mm around the imipenem-EDTA disc
compared to imipenem disc alone was recorded as a MBL producing
strain.[8,9]E.coli (ATCC 25922) and P. aeruginosa (ATCC 27853) were used as
control strains.[10]
DETERMINATION OF MINIMUM INHIBITORY CONCENTRATION
(MIC) OF IMIPENEM
All isolates of Pseudomonas aeruginosa were tested by Macrobroth
dilution method for their MIC against imipenem. Standard strain of
P.aeruginosa (ATCC 27853) was used as control. Results were interpreted as
per CLSI 2011 guidelines.14 MIC values of ?4µg/ml, 8µg/ml and ?16µg/ml
were interpreted as sensitive, intermediate and resistant respectively .
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The panel of antibiotics included in the antimicrobial sensitivity testing
for Gram negative bacilli (Himedia, Mumbai)
Antibiotic
Zones Of inhibition
Resistant Intermediate Sensitive
Amikacin 30?g 14 15-16 17
Ampicillin 10?g 13 14-16 17
Ceftazidime 30?g 14 15-17 18
Cefotaxime 30?g 14 15-22 23
Ciprofloxacin ??g 15 16-20 21
Gentamicin 10?g 12 13-14 15
Imipenam 10 ?g 13 14-15 16
Ofloxacin ??g 12 13-15 16
Cefaperazone-Sulbactum 75/30 ?g 15 16-20 21
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The panel of antibiotics included in the antimicrobial sensitivity testing
for Gram positive cocci
Antibiotic
Zones of inhibition
Resistant Intermediate Sensitive
Amikacin 30?g 14 15-16 17
Ampicillin 10?g 28 - 29
Cotrimoxazole 1.25/23.75 ?g 10 11-15 16
Cefotaxime 30?g 14 15-22 23
Ciprofloxacin ??g 15 16-20 21
Chloramphenicol 30 ?g 12 13-17 18
Amoxycillin-Clavulanic acid 20/10?g 19 - 20
Vancomycin 30?g 12 13-15 16
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EXTENDED SPECTRUM ? LACTAMASE (ESBL) DETECTION
METHODS:
1) Screening method:
Isolates of gram negative bacilli showing the following resistance
pattern were considered to be possible ESBL producing strains.
Antibiotic zone diameter for possible ESBL producing strain:
? Ceftazidime (30?g) ? 22mm
? Cefotaxime(30 ?g) ? 27mm
? Ceftriaxone(30 ?g) ? 25mm
? Aztreonam (30 ?g) ? 27 mm.
2) CLSI phenotypic confirmation method:
          With a sterile bacterial loop, 3-5 identical colonies were picked from a
fresh overnight grown culture and inoculated into 5 ml of nutrient broth. The
broth was incubated at 35°C for 2-4 hrs and  turbidity matched with 0.5
McFarland standard. Lawn culture of the test organism was made on to MHA
plate (Himedia, Mumbai). Antibiotic discs Ceftazidime   (CAZ 30?g) and
Ceftazidime/ Clavulanic acid (CAZ/ CA 30?g/ 10?g ) were placed on the
plate and incubated at 35°C overnight. An increase in zone diameter of 5mm
or more for Ceftazidime/ Clavulanic acid  compared to Ceftazidime   alone
confirmed an ESBL producing organism .
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3.  Double disc diffusion synergy test
In this test, discs of third generation cephalosporins and augmentin
(20?g/10?g) (Himedia, Mumbai) were kept 30mm apart, from centre to centre
on inoculated Muller-Hinton Agar(MHA). A clear extension of the edge of the
inhibition zone of cephalosporin towards augmentin disc was interpreted as
positive for ESBL production.
4.  ESBL detection strip method
The ESBL detection strip is coated with ceftazidime, cefotaxime and
cefepime on the upper half and clavulanic acid and tazobactum along with the
above mixure on the lower half in a concentration gradient. 3-5 colonies of
overnight culture of the test organism is transferred to a BHI broth and
turbidity matched to 0.5 McFarland standard. The suspension is streaked on a
MHA plate with a sterile swab and a Ezy MIC strip is placed on it with an
applicator and incubated. The value of MIC where the ellipse of growth
intersects the scale on the strip is read.
DETECTION OF METHICILLIN RESISTANCE IN
STAPHYLOCOCCUS AUREUS BY DISC DIFFUSION METHOD:
3-5 identical colonies of S.aureus isolated from overnight agar culture
plate were suspended into BHI broth and turbidity matched with
0.5Mcfarlands standard. A lawn culture of the growth was made on a MHA
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plate and Oxacillin 1?g disc was applied. Incubation was done at 35° C for 24
Hrs. According to CLSI criteria with 1?g Oxacillin disc, Zone of inhibition of
diameters of ?10,  11-12, ? 13 mm were categorized as resistant, intermediate
or susceptible respectively 14.
Minimum inhibitory concentration (MIC) of Vancomycin for gram
positive cocci
Cation adjusted Mueller Hinton broth (pH 7.2-7.4)was used.
Stock Antibiotic solution was prepared using the formula:
Stock antibiotic solution was prepared using the formula: w =× C
      1000
W  = ---------------------- x V x C
P
Where P= potency of the antibiotic corresponding to the base.
P= 950/1000 mg for vancomycin (Himedia)
V = volume of the stock solution in ml
C =final concentration of the antibiotic solution (1024?g/ml)
W = weight of the antibiotic to be dissolved
2 rows of sterile test tubes arranged in a rack (one for test and another
for ATCC control).In a universal container 8ml of broth containing the
working stock solution (128 ?g/ml concentration) is prepared and 1ml
transferred to the first tube in each row. With a fresh pipette 4ml of broth
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added to 4ml of the working stock solution and 1ml transferred to the second
tube of each row. Further dilutions are prepared as per requirement.
1 ml of the antibiotic free broth is kept in the last tube for growth
control. Sterility controls for the antibiotic solution is kept.
Test organism inoculated to one row and ATCC control strain to the
second row.
Test inoculum is prepared by transferring 3-5 identical colonies from
overnight growth of the test organism to 4.5 ml of MH broth, incubated at 35o
C for 2 – 6 hours and turbidity matched with 0.5 McFarland standard which
contains approximately
1-2 x 108 CFU/ml. The suspension is diluted 1 in 100 times to attain a
final concentration of 5 x105 CFU/ml. 1ml of this dilution is added to the
tubes containing antibiotic solutions. The racks incubated at 35o C for 24
hours.
The lowest concentration of the antibiotic in which there is no visible
growth is inferred as the MIC break point of vancomycin for the test
organism.
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RESULTS
A total of 426 shunt related procedures were performed in 397 patients
over a period of one year from November 2011 to October 2012 which
included 275 primary VP Shunt insertions and 151 shunt revision surgeries
like removal ,reinsertion, exteriorization and EVD placements performed in
122 patients. 21 patients had undergone more than one revision surgery.
122 patients who developed signs and symptoms of shunt
malfunction/infection were included in the study group.
Table 1  : Patients category
Nature of Surgery
Children(<12
yrs)
Adult(>12 yrs) Total
Primary VP Shunt
Insertions
108
(27.20%)
167
(42.07%)
275
(69.27%)
Shunt
Revisions
98
(24.69%)
24
(6.04%)
122
(30.73%)
Total
206
(51.89%)
191
(48.11%)
397
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Paediatric population was categorized under 12 years of age and adult
population was categorized above 13 years of age.
External ventricular drains were placed in 7 patients with shunt
infections. 3 patients underwent radiotherapy for intracranial mass. 4 patients
were on antituberculous treatment. 1 patient underwent tracheostomy for
ventilator support and also developed pressure sores over the sacrum.
Table 2 : Sex distribution
Male Female
Children Adult Total Children Adult Total
110
(27.71%)
129
(32.49%)
239
(60.20%)
96
(24.18%)
62
(15.62%)
158
(39.80%)
Among the 397patients who underwent shunt related procedures the
male population was considerably higher (60.2%) than the female population
(39.8%).
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Table 3 : Age distribution of patients who
underwent primary VP shunt insertion
Age distribution M F Total Percentage
Children
0-3Months 14 21 35 12.73%
4-6Months 7 8 15 5.45%
7-12Months 5 2 7 2.55%
1-2Years 7 1 8 2.91%
3-5Years 5 8 13 4.73%
6-10Years 6 10 16 5.82%
11-12Years 9 5 14 5.1%
Total 53 55 108 39.27%
Aduilts
13-20Years 10 8 18 6.55%
21-30Yrs 21 9 30 10.91%
31-40Yrs 25 9 34 12.36%
41-50Yrs 22 11 33 12.00%
51-60Yrs 19 12 31 11.27%
>60Yrs 16 5 21 7.64%
Total 113 54 167 60.73%
Among the 275 patients who underwent primary VP shunt insertions,
108 patients were children (39.27%) and 167 patients were adults (60.73%).
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Table 4  : Age distribution of patients who underwent shunt revisions
Age M F Total Percentage
Children
0-3Months 3 5 8 6.56%
4-6Months 5 3 8 6.56%
7-12Months 18 8 26 21.31%
1-2Years 6 11 17 13.93%
3-5 Years 15 8 23 18.85%
6-10 Years 8 6 14 11.48%
11-12 Years 2 0 2 1.64%
Total 57 41 98 80.33%
Adult
13-20 Years 2 4 6 4.92%
21-30 Years 4 1 5 4.10%
31-40 Years 5 0 5 4.10%
41-50 Years 2 2 4 3.28%
51-60 Years 1 0 1 0.82%
>60 Years 2 1 3 2.46%
Total 16 8 24 19.67%
Among the 122 patients, who underwent shunt revision surgeries, 98
patients were children (80.33%) and 24 patients were adults.(19.67%)
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Table 5  :Etiological profile of hydrocephalus of the study population
Etiology Children(<12yrs)
Adult
(>12 yrs) Total Percentage
Congenital Malformations
Dandy Walker
malformation
6 (4.92%) -
6
(4.92%)
4.92
Aqueductal Stenosis 6 (4.92%) 1 (0.82%) 7 5.74
Meningomyelocele 9 (7.38%) - 9 7.38
Arachnoid cyst 4 (3.28%) - 4 3.28
Others 24 (19.67%) - 24 19.67
Infective
Post meningitic 16(13.11%) 4 (3.28%) 20 16.39
PostTBM
(Tuberculous
meningitis)
12 (9.84%) 2 (1.64%) 14 11.48
Tuberculoma 3 (2.46%) 2 (1.64%) 5 4.10
Intracranial abscess 1 (0.82%) - 1 0.82
Intracranial tumours 8 (6.56%) 3 (2.46%) 11 9.02
Haemorrhage
Spontaneous 1 (0.82%) 5 (4.1%) 6 4.92
Post traumatic - 3 (2.46%) 3 2.46
Others 8 (6.56%) 4 (3.28%) 12 9.84
Total 98 24 122 100
Congenital malformations were the most common underlying cause for
the development of hydrocephalus in children (45.24 %).Intracranial
hemorrhage was the most common cause for hydrocephalus in adults (6.56%).
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Table 6  : Category of patients in the study group
Patients
Underwent one
revision (%)
Underwent
multiple
revisions (%)
Total
(%)
Number 101 (82.79) 21 (17.21) 122
Culture positive 26 (21.31) 16 (13.11) 42 (34.42)
Culture negative 75 (61.48) 5 (4.10) 80 (65.58)
Among the 122 patients treated for malfunction 42 patients were
culture positive, with an infection rate of 10.58%, 21 patients underwent a
total of 50 revision surgeries. Of them 15 underwent two revisions (30), 5
patients underwent 3 revisions (15) and 1 patient underwent 5 revisions.
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Table 7-Interval between VP shunts insertion and malfunction
Duration
No of cases infected
(Culture positive)
No of cases uninfected
(Culture negative)
Total Percentage
<1Month 9 (7.38%) 25 (20.49%) 34 27.87
2-3Months 8 (6.56%) 29 (23.77%) 37 30.33
4-6Months 6 (4.92%) 14 (11.48%) 20 16.39
7-
12Months
7 (5.74%) 6 (4.92%) 13 10.66
1-2Months 8 (6.56%) 6 (4.92%) 14 11.48
>2years 4 (3.28%) 0 4 3.28
Total 42 (34.42%) 80 (65.58%) 122 100
Majority of the shunt infections were noted to occur within 1 month of
primary insertion 27.87%. About 74.59% of infections occurred within 6
months of postoperative period.
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Table 8- Clinical presentation of patients
Symptoms No of cases(n=122) Percentage
Fever 38 31.15
Vomiting 42 34.43
Head ache 21 17.21
Altered sensorium 16 13.11
Visual disturbances 6 4.92
Seizures 14 11.56
Progressive increase in head
size
18 14.75
CSF leak 9 7.38
Abdominal distension 4 3.28
Extrusion through
anus/abdominal wound
3 2.46
Wound discharge 21 17.21
Shunt tract inflammation 12 9.84
Fever (31.75%) , vomiting (34.43%) wound discharge (17.21%) and
altered sensorium  (13.11%) were the most common symptoms of
presentation in the pediatric and adult patients. Seizures and progressive
increase in head size were more common in children. Headache and visual
disturbances were more common in adults.
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Table 9- Correlation of age as a risk factor for shunt infection
Age No of cases
No. infected
(n=42)
Percentage for 42
0-3M 43 4 9.52
4-6M 23 5 11.90
7-12M 33 15 35.71
1-2Yr 25 6 14.29
3-5Yr 36 4 9.52
6-10Yr 30 2 4.76
11-12Yrs 0 0 0
13-20Yrs 40 2 4.76
21-30Yrs 35 1 2.38
31-40Yrs 39 2 4.76
41-50Yrs 37 - 0
51-60Yrs 32 1 2.38
>60Yrs 24 - 0
Total 397 42 100%
The maximum incidence of infection was found in infants between 7 to
12 months of age (35.71%). A high incidence of infection following shunt
insertions was observed in children below 2 years of age (71.43 %).
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Table 10 : Correlation of Etiology of hydrocephalus
as a risk factor for infection
Etiology
No. of
patients
with
malfunction
No. of patients infected
Percentage
(%)Children(%) Adults(%) Total
Congenital
Malformation
50(40.98%) 18(42.86) 1(2.38) 19
45.24
Meningitis 40(32.79%) 9(21.43) 2(4.76) 11
26.19
Intracranial
mass
11(9.02%) 5(11.9%) 0 5
11.90
Intracranial
hemorrhage
9(7.38%) 1(2.38%) 3(7.14) 4
9.52
Others
(Idiopathic)
12(9.84) 3(7.14) 0 3
7.14
Total 122 36 6 42 100
Shunt infections were more common in infants operated for
hydrocephalus due to congenital malformations (42.86%) and meningitis
(21.43%).In adults, shunt infections occurred with increasing frequency in
patients with intracranial hemorrhage (7.14%) and following
meningitis.(4.76%)
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Table 11- Correlation of CSF gram stain with infection
Gram Staining
(n=81)(%)
Culture Positive n=31(%) Culture Negative n=50(%)
Positive
30(37.04)
26(32.1) 4(4.94)
Negative
51(62.96)
5(6.17) 46(56.79)
Gram staining was done for all the 81 CSF specimens received
.Among the 30 CSF specimens which showed pus cells and organisms, 26
were culture positive(32.1%) and 4 were culture negative.(4.94%)
Table 12-Correlation of CSF biochemical parameters with infection
Variable Infected n=42 Uninfected(%)
CSF PROTEIN >45mg/dl 28(66.67%) 4(9.52)
CSF GLUCOSE<45mg/dl 27(64.29) 2(4.76)
Raised Cell Count 3(7.14) -
Among the 42 patients who were culture positive, a significant
proportion of patients showed elevated protein (66.67%) and reduced glucose
(64.29%). Only 3 patients had raised cell count (7.14%).
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Table 13- Correlation of Blood counts with Shunt infection
Variable No. of Infected cases Percentage
Increased total count 30 71.43
Differential count
(Neutrophilia)
28
66.67
Reduced Haemoglobin 14 33.33
 A significant  proportion of patients who were culture positive showed
raised white blood cell count and neutrophilic leucocytosis (66.67%). 14
patients had anemia(33.33%)
Table 14- Details of samples processed from cases of malfunction
Sample No.
Culture positive
Culture
NegativeFirst
sample
Repeat
sample
Total
CSF 81 25(30.86) 6(7.41) 31(38.27) 50(61.73)
Shunt tube 67 29(43.28) 10(14.93) 39(58.21) 28(41.79)
Pus 9 6(66.67) - 3(66.67) 3(33.33)
Peritubal
collection
3 2(66.67 - 2(66.67) 1(33.33)
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Table15- Pathogens isolated from cases of shunt infection
Type of organism Percentage
Gram positive cocci 47.73%
Gram negative bacilli 52.27%
Total 100%
The study highlighted a slightly higher rate of CSF shunt infection
with gram negative bacilli (52.27%) as compared to that of gram positive
cocci (47.73%)
Table 16- Microbiological Profile of Infected Ventriculoperitoneal Shunts
Organisms Number (n =44) Percentage
Staphylococcus epidermidis 10 22.73
Staphylococcus aureus 9 20.45
Pseudomonas aeruginosa 7 15.91
Escherichia coli 3 6.82
Klebsiella oxytoca 3 6.82
Proteus vulgaris 3 6.82
Acinetobacter baumanii 3 6.82
Klebsiella pneumoniae 2 4.55
Proteus mirabilis 2 4.55
Enterococcus faecalis 1 2.27
S.lugdunensis 1 2.27
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S. epidermidis was the predominant pathogen isolated (22.73%) from
cases of shunt infection. Organisms like S.aureus (20.45%) and Pseudomonas
aeruginosa(15.91%) also showed a high incidence of infection.
The other pathogens commonly isolated were E.coli, K.oxytoca,
K.pneumoniae, Proteus mirabilis and Acinetobacter baumanii.
Enterococcus faecalis(2.27%) and S.lugdunensis (2.27%) were isolated
from one patient each.
Table 17- Pathogens isolated in Polymicrobial Infection
Organisms Number of isolates
S.epidermidis + Proteus mirabilis 2
S.aureus + Acinetobacter baumanii 2
Mixed infection was seen in two patients, with one organism isolated
being a gram positive cocci and the other, a gram negative bacilli. Both
occurred in patients who underwent external drainage procedures of the distal
end of ventriculoperitoneal shunt.
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Table 18- Pathogens isolated from blood culture of Shunt Malfunctions
Patient No Blood Culture Shunt tip/CSF
1 S.epidermidis S.epidermidis
2 Klebsiella oxytoca No growth
3 Enterococcus faecalis No growth
Although bacteraemia was seen in 3 patients with VP shunt
malfunction, only one patient had a similar pathogen -S.epidermidis isolated
from both the blood culture and shunt tip.
Other 2 patients who had blood stream infection with K.oxytoca and
Enterococcus faecalis respectively had a negative culture from shunt tip and
CSF.
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Table 19- Antibiotic sensitivity pattern of gram positive cocci
Organism
A
m
pi
ci
lli
n
A
m
ik
ac
in
C
ip
ro
flo
xa
ci
n
C
ef
ot
ax
im
e
A
m
ox
yc
ill
in
-
C
la
vu
la
ni
c 
Ac
id
C
ot
rim
ox
az
ol
e
Va
nc
o
C
hl
or
am
ph
en
ic
ol
H
ig
h 
le
ve
l G
en
ta
S.epidermidis
(10) 4(40) 6(60) 5(50) 4(40) 8(80) 4(40) 10(100)
6(60) -
S.lugdunensis
(1) 1(100) 0 1(100) 1(100) 1(100) - 1(100)
1(100) -
S.aureus (9) 4(44.44) 7(77.78) 4(44.44) 3(33.33) 7(77.78) 5(55.56) 9(100) 5(55-56) -
Enterococcus
faecalis (1) - 1(100) 0 0 1(100) 0 1(100) 1(100)
The gram positive cocci showed a high sensitivity spectrum to
amoxycillin- clavulanic acid, amikacin and chloramphenicol. All the strains
isolated were sensitive to Vancomycin (100%)
Table 20 - Antibiotic sensitivity pattern of Gram negative bacilli
Organisms
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P.aeruginosa
n=7
6
(85.71)
3
(42.86)
-
4
(57.14)
3
(42.86)
4
(57.14)
6
(85.71)
6
(85.71)
4
(57.14)
E.coli
n=3
3
(100)
1
(33.33)
0
1
(33.33)
1
(33.33)
-
3
(100)
-
1
(33.33)
Kleb. Oxytoca
n=3
2
(66.67)
1
(33.33)
1
2
(66.67)
1
(33.33)
-
3
(100)
-
1
(33.33)
Kleb. pneumoniae
n=2
1
(50)
2
(100)
0
2
(100)
1
(50)
-
2
(100)
-
1
(50)
Pr.vulgaris
n=3
3
(100)
2
(66.67)
1
(33.33)
2
(66.67)
1
(33.33)
-
3
(100) -
1
(33.33)
Pr.mirabilis
n=2
1
(50)
1
(50)
1
(50)
1
(50)
1
(50)
-
2
(100)
-
0
Acinetobacter
baumanii
n=3
2
(66.67)
1
(33.33)
1
(33.33)
1
(33.33)
1
(33.33)
-
2
(66.67)
3
(100)
0
68
Most of the isolates were highly sensitive to cefaperazone sulbactum
and amikacin and moderately sensitive to ofloxacin,ciprofloraxin and
garamycin. A.baumanii showed 100% sensitivity to Imipenam and
P.aeruginosa 85.71% sensitivity.
Table 21- Gram Negative bacilli with ESBL production
Organism No. of cases ESBL production (%)
E.coli 3 2(66.67)
S.pneumoniae 2 1(50)
K.oxytoca 3 2(66.67)
Proteus mirabilis 2 2(100)
ESBL production was checked by disc diffusion method and confirmed
by double disc synergy test and ESBL strip method.
Table 22- Gram negative bacilli with metallo ? latamanse production
Organism No of isolates MBL
Ps.aeruginosa 7 1(14.29)
MBL production was detected using Imipenem disc for screening and
confirmed by MHT and CDT with Imipenem and Imipenem with EDTA.
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Table 23- Detection of MRSA among isolates of S.aureus
Organism Isolates Disc diffusion method strains
S.aureus 9 7(77.78)
Methicillin resistance was screened using oxacillin disc (1? g) by disc
diffusion method.
Table 24-MIC of Vancomycin for Gram positive cocci
Organism 0.25?g/dl 0.5?g/dl ??g/dl ??g/dl ??g/dl ??g/dl
S.epidermidis (10) - 3 5 1 1 -
S.aureus (9) 1 4 4 - - -
S.lugdunensis (1) - - - 1 - -
E.faecalis (1) - - 1 - - -
All the strains of Staphylococcus aureus (? 2?g/dl). and CONS ??
??g/dl) were sensitive to vancomycin The MIC breakpoints of the isolates
were between (0.25?g/dl - 4?g/dl)
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Table 25 MIC of Imipenam for isolates of Pseudomonas aeruginosa
Organmism No isolates 1 2 4 8 16 32
P.aeruginosa 7 2 3 1 - - 1
Table 26 - Outcome of Patients With shunt infection
Outcome
Children
n= 36
Adult
n=6
Total
N= 42
Survived 35(83.33) 5(11.91) 40(95.24)
Died 1(2.38) 1(2.38) 2(4.76)
The mortality rate was 4.76% (1.64% among cases of shunt
malfunction ).
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Fig. 1: Ventriculoperitoneal shunt tube
Fig. 2: Infected  ventricular and peritoneal catheter tips in BHI broth
Fig. 3:  A case of congenital hydrocephalus with replaced VP shunt tube
Fig. 4: A case of post menningitic hydrocephalus with shunt tract infection
Fig.5 : CT scan  image of a case of hydrocephalus with bilateral VP shunt tubes
Fig.6 : X-ray chest of a case of  hydrocephalus showing
shunt tube inside the peritoneal cavity
Fig. 7: Procedure showing insertion of
proximal catheter into the lateral ventricle
Fig. 8: Insertion of distal catheter into the peritoneal cavity
Fig.9 : Direct Gram stain of CSF showing pus cells and GPC
Fig. 10: Direct Gram stain of CSF showing  pus cells and GNB
Fig. 11: Escherichia coli on McConkey agar plate
Fig.12 : Biochemical reactions of Escherichia coli
Fig. 13: Tube coagulase test of Staphylococcus aureus
Fig.14 : Antibiotic sensitivity of S.epidermidis on MHA
Fig. 15: Biochemical reactions of S.epidermidis
Fig. 16: Biochemical reactions of S.lugdunensis
Fig. 17: Biochemical reactions of Acinetobacter baumanii
Fig.18: Biochemical reactions of Proteus vulgaris
Fig. 19: Antibiotic sensitivity of Pseudomonas aeruginosa
Fig. 20: MIC of Imipenam for Pseudomonas aeruginosa (MIC-32 ?g/ml)
Fig. 21: DDST for ESBL detection using
cefotaxime, ceftazidime and amoxicillin-clavulanic acid
Fig. 22:Combined disc test for
ESBL detection using ceftazidime and  ceftazidime + clavulanic acid
Fig. 23: Modified Hodge Test for MBL detection
Fig. 24: Combined disc test for MBL detection using
Imipenam and Imipenam + EDTA
Fig. 25: E-test for triple ESBL detection using Ezy MIC strips
With test strain and ATCC E.coli 25922
Fig. 26: MIC of Vancomycin for S.aureus (MIC 0.5?g/ml)
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DISCUSSION
Insertion of ventriculoperitoneal shunt is the mainstay in the
management of hydrocephalus in children and adults enabling the drainage of
excess cerebrospinal fluid (CSF) from the cerebral ventricles into the
peritoneal cavity. Infection of CSF shunts is one of the serious complications
in the post operative period and also in the long run, resulting in increased
morbidity and mortality. Seizures and neurological disturbances occur as a
sequelae of infection, thus disabling the patient.
This study was performed with the intention of evaluating the
incidence of infection, to identify the predisposing risk factors and the
causative pathogens involved, to determine their antibiotic sensitivity and
resistance pattern and to suggest an empirical antibiotic therapy for the
patients.
During the study period altogether 2120 surgeries were performed by
the neurosurgeons including 426 CSF shunt related procedures (20.1%)
performed in 397 patients. Of these, 275 surgeries were primary VP shunt
insertions (64.55%) and 151 were shunt revisions (35.45%). Nearly 1/3rd of
the shunt procedures performed were shunt revisions (Table - 1). Estimation
of the data from the National Hospital Discharge Survey in the US from 1988
to 1991 reveals that 33,000 patients underwent shunt placement procedures
annually, with nearly half of these for revision of an existing shunt.3,45
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In this study, 60.2% of shunt related procedures were performed in
males and 39.8% in females. In the study group who met the eligibility
criteria and underwent shunt revisions, 59.84% were males and 40.16% were
females. In a study conducted by McGirt et al 52% of the shunts were placed
in male patients.40(Table - 2)
In this study, 108 children (39.27%) and 167 adults (60.73%)
underwent primary VP shunt insertions. Considering those who developed
malfunction and subsequently underwent revisions the pediatric population
was significantly higher (80.33%) than the adult population (19.67%)
(Table - 4). In a study conducted by Sarguna P et al 77.78% of shunt
infections was reported in patients below 15 years of age.
The aetiology of hydrocephalus in children who required shunt
revisions in this study were congenital malformations like meningomyelocele
(7.38%), aqueductal stenosis (4.92%) and Dandy Walker malformations
(4.92%). The other common causes of hydrocephalus in children were
preceding meningitis (22.95%) and intracranial mass lesions (6.56%). In
adults the conditions frequently causing hydrocephalus were intracranial
hemorrhage (6.56%) and meningitis (4.92%) (Table - 5). In a study conducted
by A.V.Kulkarni et al in 2001, the following causes were documented for
hydrocephalus: myelomeningocele (21.7%) intraventricular hemorrhage
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(19.1%), tumors (14%), aqueductal stenosis (8%), meningitis (4%),trauma
(2.3%) and hemorrhage (1.3%).35
The common clinical manifestations of patients with shunt
malfunctions in the study group were fever (31.15%), vomiting (34.43%),
headache (17.21%), wound infection (17.21%) progressive increase in head
size (14.75%), altered sensorium (13.11%), seizures (11.48%) and CSF leak
(7.38%). Fever, vomiting and altered sensorium were the common symptoms
in both children and adults. Seizures were more common in children and
headache was more common in adults (Table - 8). In a study conducted by
Drake JM et al, the common symptoms and signs of presentation in patients
with infected CSF shunts were fever (69.2%), vomiting (31%), increased head
circumference (19.2%), wound erythema (27%), CSF leak (15.4%) and
seizures (3.8%).19
Among the 397 patients who underwent CSF shunt procedures, 122
symptomatic patients underwent revision surgeries. Of these, 101 patients
(82.79%) underwent one revision surgery and 26 of these were culture
positive. (21.31%) (Table- 6). 21 patients underwent multiple revisions and 16
of them were culture positive (13.11%). These 21 patients underwent a total
of 50 revision procedures. Of them 15 underwent 2 revisions (30), 5 patients
underwent 3 revisions (15) and 1 patient underwent 5 revisions. The overall
infection rate in the study was 10.58%.
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The incidence of shunt infection in various studies is in the range of 4
to 15%. In a study of VP shunt infection conducted by M.F Cotton et al 39
infections were identified from 372 shunt procedures giving an incidence of
10.5%.This finding was similar to the present study.42
Majority of shunt infections occur in the early post operative period. In
this study 27.87% of VP shunt infections occurred within 1 month of shunt
infection, 58.2 % of infections within 3 months and 74.59% occurred within a
period of 6 months post operatively (Table 7).  Study conducted by Choux et
al reported that 66% of infections were diagnosed within 1 month of surgery
and nearly 80% within 6 months.13
The most common risk factor associated with shunt related infection is
the age of the patient. This study also highlights age as a risk factor for shunt
infection. About 68.12% of infections occurred in infants under 1 year of age.
A high incidence of infection was noted in children between 7 and 12 months
(35.71%) followed by infants less than 6 months of age (21.43%).The
incidence of infection was relatively less in patients aged 5 years and above
(Table - 9). Casey et al had observed in a cohorts study that the infection rate
in children less than 6 months of age was 19% compared to 7% in children
above that age.11
Young age is one of the main risk factors for acquiring shunt infection,
the reason suggested being an immature immune system and a higher
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concentration of microbial flora on the skin with more adherent strains.2 Other
significant risk factors for CSF shunt infections include premature
birth,etiology of hydrocephalus, previous shunt infection and shunt revisions.
In this study, shunt infections were more common in children with
hydrocephalus due to congenital malformations (42.86%), meningitis
(21.43%) and intracranial mass (11.91%). In adults, infection was common in
patients with hydrocephalus due to intracranial hemorrhage (7.14%) and
meningitis (4.76%) (Table - 10).  This was similar to a study conducted by
Suzan Sacar et al which reported that shunt infections were common in
congenital hydrocephalus (32%), meningitis (23%) and intracranial mass
(23%) and less common in patients with intracranial hemorrhage (9%).58
In this study, it was also observed that there was a marked association
of shunt infection with previous shunt revisions. 21 patients had undergone
more than one revision surgery and 16 of them were culture positive
(76.19%).Whereas in those who underwent one revision surgery (101) only
26 were culture positive (25.74%). McGirt et al in their study had observed a
4 fold increase in the risk of shunt infection in patients with previous shunt
infection.40
Measurement of CSF glucose and protein levels and cell counts can
prove to be very valuable in identifying shunt infection. In this study, CSF
protein levels were raised in 66.67% of infected patients and glucose levels
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were reduced in 64.29% of infections. Most of the CSF specimens with
positive culture were acellular.CSF pleocytosis was observed only in 7.14%.
(Table - 12)
Macroscopic examination of the CSF specimens was also not
indicative of underlying infection. Of the 81 CSF specimens received, 31
were culture positive but only 4 specimens were turbid.
Gram staining of CSF specimens has been shown to be very useful for
preliminary diagnosis of infection and identification of the nature of pathogen
involved.
In this study, gram staining was done for all the CSF specimens. Of the
30 specimens which showed pus cells and presence of organisms, 26 were
culture positive (32.1%), and 4 were culture negative (4.94%). Gram staining
was positive more in infections with gram positive cocci (16) than Gram
negative bacilli (10). Of the 51 CSF specimens which revealed no pus cells or
organisms, 5 were culture positive (6.17%). (Table-11)
Analysis of these results shows that Gram staining was positive in
83.87% of culture positive specimens and negative in 16.13%. A study done
by Nelson et al showed gram staining positivity in 82% of gram positive cocci
and 91% of gram negative bacilli.44
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Blood counts analyzed in the study showed leukocytosis in 71.43% of
shunt infections and anaemia in 33.33% was seen only in pediatric
patients.(Table - 13)
In this study, 81 CSF specimens, 67 shunt tubes, 9 pus specimens and 3
peritubal collections were collected from 122 patients with shunt
malfunction.Of the 81 CSF specimens, 25 initial specimens were culture
positive (30.86%). 6 repeat CSF specimens obtained from previously infected
patients were also culture positive (7.41%). Of the repeat specimens, same
pathogen was isolated from 5 cases and a different organism from one.
Among the 67 shunt tubes processed, 29 specimens obtained for the
first time from patients were culture positive (43.28%). 10 specimens
obtained from the same patients were also culture positive, 8 of them with the
previous pathogen isolated and 2 with a different organism.Of the other
specimens, 66.67% each of pus and peritubal collections were culture
positive.(Table -14)
In this study, 44 bacterial organisms were isolated from 42 patients
with shunt infections. The causative pathogens included 21 isolates of gram
positive cocci (47.73%) and 23 isolates of gram negative bacilli (52.27%). Of
these, monomicrobial infection occurred in 40 patients and polymicrobial
infection in 2 patients (2 isolates each).(Table -15)
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The commonest organism isolated in this study was Staphylococcus
epidermidis (22.73%) [Table 16]. Other common pathogens isolated were
Staphylococcus aureus (20.45%) and Pseudomonas aeruginosa (15.91%).
Other organisms less commonly isolated were gram negative bacilli like
Escherichia coli (6.82%),Klebsiella oxytoca(6.82%),Proteus vulgaris (6.82%)
Acinetobacter baumanii (6.82%),Klebsiella pneumoniae (4.55%),Proteus
mirabilis (4.55%) and gram positive cocci like Enterococcus faecalis (2.27%)
and Staphylococcus lugdunensis (2.27%). A study performed by Sharpio S et
al reported isolation of Staphylococcus epidermidis (45%), Staphylococcus
aureus (20%), Micrococcus (5%) and gram negative bacilli (15%).
Mixed infection occurred in 2 patients with following isolates-
Staphylococcus epidermidis +Proteus mirabilis and Staphylococcus aureus
+Acinetobacter baumanii. Both the patients with mixed infection had
previously undergone external drainage procedures of the peritoneal end of
VP shunt tube. (Table-17)
Bacteraemia was observed in 3 patients with VP Shunt malfunction
Staphylococcus epidermidis was isolated from blood, shunt tip and CSF of 1
patient with VP Shunt infection. Klebsiella oxytoca and Enterococcus faecalis
were the pathogens isolated from blood culture of two other patients, in whom
the CSF culture was negative.(Table-18)
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All the isolates of gram positive cocci were sensitive to Vancomycin
(100%).Most of the isolates of Staphylococcus epidermidis were moderately
sensitive to amoxycillin-clavulanic acid (80%), amikacin( 60%) and
chloramphenicol (60%). Isolates of Staphylococcus aureus were found to be
more sensitive to amoxycillin-clavulanic acid (77.78%) and amikacin
(77.78%). 7 strains were methicillin resistant (77.78%). Staphylococcus
lugdunensis was sensitive to ampicillin, ciprofloxacin, cefotaxime, and
amoxycillin-clavulanic acid. Enterococcus faecalis was sensitive to
amikacin, amoxycillin-clavulanic acid and high level gentamicin.(Table-19)
In a study conducted by Poonam Sharma et al, 88% of the CONS
isolated were methicillin resistant. All the isolates were sensitive to
vancomycin(100%) and 75% of isolates were sensitive to chlramphenicol and
70% to clindamycin. Most of the strains were resistant to other drugs.49
Most of the gram negative bacilli were sensitive to cefoperazone-
sulbactum. Pseudomonas aeruginosa showed high sensitivity to
amikacin,cefaperazone-sulbactum and imipenam (85.71% each). E.coli was
100% sensitive to amikacin and cefaperazone-sulbactum, but mostly resistant
to other drugs. Klebsiella oxytoca was moderately sensitive to amikacin and
ofloxacin (66.67%). Isolates of Klebsiella pneumoniae were 100% sensitive
to, ofloxacin and cefaperazone-sulbactum. Proteus vulgaris was highly
sensitive to amikacin and cefaperazone- sulbactum (100%) and moderately
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sensitive to ofloxacin (66.67%). Proteus mirabilis was highly sensitive to
cefaperazone-sulbactum (100%), but moderately sensitive to other drugs.
Acinetobacter baumanii was highly sensitive to imipenam (100%) and
moderately sensitive to amikacin and cefaperezone-sulbactum (66.67%).
Most of the strains isolated in this study were detected to be ESBL
producers. ESBL production was observed in 66.67% of isolates of
Escherichia coli and Klebsiella oxytoca, 50% of isolates of Klebsiella
pneumoniae and 100% of Proteus mirabilis. One strain of Pseudomonas
aeruginosa (14.29%) isolated in this study was detected to be an metallo ?
lactamase producer.(Table-21 &22)
Minimum inhibitory concentration of imipenam was tested for isolates
of Pseudomonas aeruginosa. 6 isolates were interpreted to be sensitive to
imipenam  with MIC break points ranging from 1 ?g/ml to 4 ?g/ml. One
isolate was resistant with MIC break point of 32 ?g/ml.(Table-25)
          Minimum inhibitory concentration of vancomycin tested for gram
positive cocci showed all srains of Staphylococcus epidermidis,
Staphylococcus aureus, Enterococccus faecalis and Staphylococcus
lugdunensis to be sensitive to vancomycin with MIC break points ranging
from 0.25 ?g/ml to 2 ?g/ml  for Staphylococcus aureus and 0.5 to 4 ?g/ml
for CONS and Enterococcus faecalis. (Table -24)
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In this study, Staphylococcus epidermidis was the commonest
organism isolated (22.73%), which showed only moderate sensitivity to drugs
except vancomycin and most of these strains were isolated from pediatric
patients with CSF leak or wound infection suggesting the possibility of
virulent disease causing isolates than colonizing isolates. This reflects the
higher skin carriage rate of resistant strains of Staphylococcus epidermidis
from the hospital environment.
In this study, Gram negative bacilli were isolated in significant
numbers. Most of them occurred in patients with bowel perforation ,peritubal
collection and in those who had undergone prior revisions with external
drainage procedure .
The treatment protocol of VP shunt infection in the neurosurgery
department consists of removal of the infected shunt, appropriate
antimicrobial therapy and reinsertion of a new shunt after a period of
antibiotic therapy with some form of external drainage procedure.For those
undergoing first time insertions, perioperative prophylactic antibiotics were
given intravenously with ceftriaxone and amikacin.
During the study period, 2 patients with shunt infection died
giving a mortality rate of 4.76 % , 1 patient was a case of post-TBM
hydrocephalus and developed shunt infection following bowel perforation
with many relapses and underwent 5 revision surgeries. The initial isolate was
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Escherichia coli and the subsequent isolates were Pseudomonas aeruginosa
which was a MBL producer. The other patient was a case of post traumatic
hydrocephalus with sub arachnoid hemorrhage who developed shunt infection
and died.
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SUMMARY
? This study was done for a period of 1 year involving 397 patients of all
age groups and both sexes, who underwent a total of 426 shunt related
procedures. 275 patients underwent primary ventriculoperitoneal shunt
insertions and 122 patients underwent shunt revisions.
? 122 patients who developed symptoms and signs of shunt malfunctions
were included in the study population. Of them 101 patients underwent
single revision and 21 patients underwent multiple revisions during the
study period.
? 42 patients were infected giving an infection rate of 10.58%.16 patients
had relapses and underwent multiple revisions.
? The study group included 59.84 % of males and 40.16% of females.
? Children accounted for 80.33% of the study population and adults
accounted for 19.67 %.
? The common aetiological conditions for hydrocephalus necessitating
shunt were congenital malformations(40.98%), meningitis (32.79%),
intracranial mass (9.02%)and hemorrhage( 7.38%.)
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? The clinical features of patients with shunt malfunction included fever,
vomiting, headache, seizures, altered sensorium, wound discharge and
CSF leak.
? Majority of the shunt infections occurred within a period of 1 month of
shunt insertion (27.87%) and most of the infection had occurred within
6 months(74.59%).
? Most of the infections occurred in children less than 1 year of age
(57.14%), thus proving young age as a significant risk factor.
? The incidence of shunt infection was remarkably higher in patients
with hydrocephalus due to congenital malformations (45.24%) and
meningitis (26.19%).
? Abnormal biochemical parameters were observed in most of the cases
with shunt infection with reduced CSF glucose levels (64.29%) and
raised CSF protein levels (66.67%).
? Polymorphonuclear leukocytosis and anaemia were seen in a
significant proportion of infected cases.
? Gram staining was positive in 37.04% of CSF specimens. 86% of these
were culture positive.
85
? Altogether 44 pathogens were isolated, gram negative bacilli (52.27%)
predominating over gram positive cocci (47.73%) unlike several
studies.
? The commonest pathogen isolated was Staphylococcus epidermidis
(23.73%) and the other common pathogens isolated were
Staphylococcus aureus( 20.45%) and Pseudomonas aeruginosa
(15.91%). The less commonly isolated organism were Escherichia coli,
Klebsiella oxytoca, Klebsiella pneumoniae , Proteus vulgaris, Proteus
mirabilis, Acinetobacter baumanii, Enterococcus faecalis and
Staphlyococcus lugdunensis .
? Mixed infection was seen in 2 patients.
? Bacteraemia was observed in 3 cases of shunt malfunction in whom
only one shunt tip/CSF was culture positive.
? Gram positive cocci were highly sensitive to vancomycin and
amoxycillin-clavulanic acid and moderately sensitive to amikacin.
? Most of the gram negative bacilli were sensitive to cefaperazone-
sulbactum and imipenam.
? Most of the strains of Staphylococcus aureus (77.78%)  isolated from
shunt infection were methicillin resistant.
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? ESBL production was also seen in more numbers in isolates of
Escherichia coli and Klebsiella oxytoca and Proteus mirabilis.
? MBL production was observed in one isolate of Pseudomonas
aeruginosa.
? MIC of vancomycin for gram positive cocci was in the sensitive range
for all isolates.
? MIC of imipenem for Pseudomonas aeruginosa for 6 isolates was in
the sensitive range. 1 isolate was resistant.
? Treatment protocol followed was shunt removal, intravenous antibiotic
therapy and shunt reinsertion which was done immediately in certain
patients or after 1 to 2 weeks of antibiotic therapy with external
ventricular drain placement as and when the conditions warranted.
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CONCLUSION
? Ventriculoperitoneal shunt infection is one of the major complications
associated with mortality and morbidity resulting in neurological
disturbances.
? The infection rate in patients with ventriculoperitoneal shunt was
10.58%.
? A large number of infections occurred in children with congenital
malformations   and following meningitis.
? Most of the infections occurred within 6 months of surgery.
? CSF gram staining and biochemical parameters were very useful n
identification of shunt infection enabling empirical antibiotic therapy.
? Staphylococcus epidermidis was the commonest pathogen isolated.
? Pseudomonas aeruginosa was isolated in many patients with external
drainage procedures suggesting nosocomial infection.
? Promising results are obtained by early removal of the shunt hardware
accompanied by appropriate antibiotic therapy until CSF culture turns
negative, followed by shunt replacement.
? With the emergence of methicillin resistant strains, ESBL and MBL
producers, diligent use of antibiotics will restrict the spread of drug
resistant strains in the  community and environment.
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ABBREVIATIONS
CLSI -  Clinical & Laboratory Standards Institute
CONS -  Coagulase Negative Staphylococci
DDST -  Double disk diffusion synergy test
ESBL -  Extended Spectrum ? Lactamases
GNB -  Gram-negative bacilli
GPC -  Gram-positive cocci
MBL -  Metallo ? Lactamases
MIC -  Minimum Inhibitory Concentration
MRSA -  Methicillin Resistant Staphylococcus aureus
S. aureus - Staphylococcus aureus
S. epidermidis - Staphylococcus epidermidis
E.coli -  Escherichia coli
P.aeruginosa - Pseudomonas aeruginosa
CSF - Cerebrospinal Fluid
VP Shunt - Ventriculoperitoneal shunts
APPENDIX
A.  STAINS AND REAGENTS
Gram staining
Methyl violet (2%) l0g
Absolute alcohol 100 ml
Distilled water (primary stain) 1 litres
Grams Iodine 10g
Potassium Iodide 20g
Acetone Decolourising agent
Carbol fuchsin 1% Secondary stain
B.  MEDIA USED
1.  Mac Conkey agar
Peptone 20g
Sodium taurocholate 5g
Distilled Water 1 ltr
Agar 20g
2% neutral red in 50% ethanol 3.5ml
10% lactose solution l00mI
Dissolve peptone and taurocholate in water by heating. Add agar
and dissolve it in steamer. Adjust pH to 7.5. Add lactose and neutral red
shake well and mix. Heat in free steam (100°C) for 1 hour, then
autoclave at 115°C for 15 minutes.
2.  Blood agar (5% sheep blood agar)
Peptone  l0g
NaCl 5g
Distilled water 1 Ltr
Agar 10g
Dissolve ingredients in distilled water by boiling, and add 5%
sheep blood(sterile) at 55°C, adjust pH to 7.4.
3.  Chocolate agar
Sterile defibrinated blood 10 ml
Nutrient Agar (melted) 100 ml
When the temperature was about 75°C, sterile blood was added
with constant agitation. After addition of blood, kept in water bath and
heating was continued till the blood changed to chocolate colour.
Cooled to about 50° C and about 15ml poured into petri dishes with
sterile precaution.
4.  Mueller- Hinton Agar
Beef infusion 300ml
Caesein hydrolysate 17.5g
Starch 1.5g
Agar 10g
Distilled water 1ltr
pH 7.4
Sterilise by autoclaving at 121ºC for 20 mins
5. Brain-heart infusion broth
Calf brain infusion 200 g/l
Beef heart infusion 250g/l
Proteose peptone 10g/l
Dextrose 2g
NaCl 5g/l
Disodium phosphate 2.5g/l
Suspend 37 g in 1000 ml of distilled water and boil to dissolve the
medium completely. Dispense as desired and sterilize by
autoclaving  at 15 lbs pressure(121oC) for 15 minutes.
C.  MEDIA REQUIRED FOR BIOCHEMICAL
IDENTIFICATION
1. Oxidase Reagent
Tetra methyl p-phenylene diamine dihyrochloride- 1% aqueous
solution.
2. Catalase
3% hydrogen peroxide
3. Indole test
Kovac’s reagent
Amyl or isoamyl alcohol 150ml
Para dimethyl amino benzaldehyde 10g
Concentrated hydrochloric acid 50ml
96 Dissolve  the  aldehyde  in  the  alcohol  and  slowly  add  the  acid.
Prepare in small quantities and store in the refrigerator. Shake gently
before use.
4. Christensen’s Urease test medium
Peptone 1g
Sodium chloride 5g
Dipotassium hydrogen phosphate 2g
Phenol red 6ml
Agar 20g
Distilled water 1 ltr
10% sterile solution of glucose l0ml
Sterile 20% urea solution l00ml
Sterilize the glucose and urea solutions by filtration. Prepare the
basal medium without glucose and urea, adjust to pH 6.8-6.9 and
sterilize by autoclaving in a flask at 121°C for 30min. Cool to about
50°C, add the glucose & urea, and tube the medium as slopes.
5. Simmon’s Citrate Medium
Koser’s medium 1 ltr
Agar 20g
Bromothymol blue 0.2% 40ml
Dispense, autoclave at 121°C for 15 min and allow to set as
slopes
6. Triple Sugar Iron medium
Beef extract 3g
Yeast extract 3g
Peptone 20g
Glucose 1g
Lactose l0g
Sucrose  l0g
Ferric citrate 0.3g
Sodium chloride 5g
Sodum thiosulphate 0.3g
Agar 12g
Phenol red 0.2% solution l2ml
Distilled water 1 ltr
Heat to dissolve the solids, add the indicator solution, mix and
tube. Sterilize at 121°C for 15 min and cool to form slopes with
deep butts.
7. Glucose phosphate broth
Peptone 5g
Dipotassium hydrogen phosphate 5g
Water 1 ltr
Glucose 10% solution 50ml
Dissolve the peptone and phosphate and adjust the pH to 7.6.
Filter, dispense in 5ml amounts and sterilize at 121°C for 15min.
Sterilize the glucose solution by filtration and add 0.25ml to each tube.
Methyl Red Reagent
Methyl Red 10mg
Ethyl alcohol 30ml
Distilled water 20ml
Voges Proskauer Reagent
Reagent A: Alpha naphthol 5g
Ethyl alcohol 100ml
Reagent B: Potassium hydroxide  40g
Distilled water 100ml
8. Peptone water fermentation test medium.
To  the  basal  medium  of  peptone  water,  add  sterilised  sugars  of
1% with indicator bromothymol blue with Durham’s tube.
Basal medium peptone water
Sugar solutions:
Sugar 1ml
Distilled water l00ml
pH 7.6.
9. Mannitol motility medium
Agar 5g
Peptone 1g
Potassium nitrate 1g
Mannitol 2g
Phenol red indicator
Distilled water l000ml
pH 7.2
10.  Phenolphthalein diphosphate agar
? Sterilize a 1% aqueous solution of sodium phenolphthalein
diphosphate by filtration and store at 4ºC
? Add 10ml of this solution to 1000ml melted nutrient agar
cooled to 50ºC and pour plates
? Grow the staphylococcus overnight at 37ºC on the medium
? Invert the plate and pour a few drops of ammonia solution SG
0.88 into the lid
? Read  as  positive  a  culture  whose  colonies  turn  bright  pink
within a few minutes. The colour soon fades.
11.  Potassium nitrate broth
Potassium nitrate (KN03) 0.2gm
Peptone 5.0gm
Distilled water 100ml
The above ingredients were mixed and transferred into tubes in 5
ml amount and autoclaved.
12.  Phenyl alanine deaminase test
Yeast Extract  3g
Dl-Phenylalamine 2 g
Disodium hydrogen phosphate l g
Sodium Chloride 5 g
Agar 12g
Distilled water 1 lr
pH 7.4
Distributed in tubes and sterilized by autoclaving at 121° C for
15 minutes, allowed to solidify as long slopes.
13. Sugar fermentation medium
Peptone 15g
Andrade’s indicator 10 ml
Sugar to be tested 20g
Water 1litre
Andrade’s indicator is prepared from 0.5% aqueous acid fuchsin
to which sufficient 1M sodium hydroxide has been added to turn the
colour of the solution yellow.
Dissolve the peptone and Andrade’s indicator in 1litre of water
and add 20g of the sugar; sugars to be tested generally include glucose,
sucrose, lactose and maltose. Distribute 3ml amounts in standard test
tubes containing an inverted Durham tube. Sterilize by steaming at 100
degree C for 30 min on 3 consecutive days.
PROFORMA
Name:                                                                                 OP/IP No.
Age:                                                                                     Ward:
Sex:                                                                                      Address:
Occupation:
Presenting Complaints:
Risk Factors:
? Age of Onset of illness
? Etiology of Hydrocephalus
? Previous Shunt infection
? Previous Shunt procedures
Physical Examination:
? Temperature
? Pulse Rate
? Blood Pressure
? Respiratory Rate
? Head Circumference
Systemic examination:
? CNS- Consciousness and Orientation
       -Gait
       -Neck Stiffness
       -Fontanelles (in infants)
       -Cranial Nerves
       -Motor System
       -Sensory System
? CVS
? RS
? P/A-Shape-Distension
      -Movements of abdominal wall
      -Tenderness / Rigidity
      -Dullness / Fluid thrill
      -Bowel sounds
Laboratory Evaluation:
? Haemoglobin
? TC,DC,ESR
? Blood Urea and Sugar
? Serum Creatinine and electrolytes
? Urine routine
? Wound Swab
? CSF analysis
-Cytology
-Protein
-Glucose
-Gram stain
-Culture
? USG Abdomen
? CT Brain
